| 1 |
28375105 | The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice. | 2016 Nov |
3 |
| 2 |
24648895 | Improvement of metabolic syndrome by irbesartan via the PPARĪ³/HGF pathway in apolipoprotein E knockout mice. | 2013 Jan |
1 |
| 3 |
19028402 | Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice. | 2010 Mar 4 |
1 |
| 4 |
18812494 | Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan. | 2008 Dec |
6 |
| 5 |
14716205 | Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan. | 2004 Feb |
1 |
| 6 |
15023892 | Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. | 2004 Mar 30 |
1 |
| 7 |
15277329 | Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. | 2004 Nov 9 |
1 |